Check out Pro
Top Companies
Recent Trades
Cluster Buys
Sectors
Blog
Join the Insiderviz Pro waitlist
Satsuma Pharmaceuticals, Inc. (STSA)
All trades on this company by insiders. Hover over bubbles for specific trade details. Drag along the graph for custom price change. Green - Buy, Red - Sell, Orange - Congress Member.
Healthcare
Biotechnology
DATE
INSIDER
COMPANY
OWNED SHARES
SHARES TRADED
PRICE
NET TOTAL
BUY
6 Jun 2023
Shin Nippon Biomedical Laboratories, Ltd.
10% Owner
Satsuma Pharmaceuticals, Inc.
(STSA)
8,423,732
+138%
30,477,312
$0.91
$27,734,354.00
BUY
6 Jun 2023
TAKANASHI KEN
Director, 10% Owner
Satsuma Pharmaceuticals, Inc.
(STSA)
24,847,694
+789%
22,053,580
$0.91
$20,068,758.00
BUY
21 Nov 2022
Leonard Braden Michael
10% Owner
Satsuma Pharmaceuticals, Inc.
(STSA)
150,000
+100%
150,000
$0.71
$106,740.00
SELL
14 Nov 2022
COMMODORE CAPITAL LP
10% Owner
Satsuma Pharmaceuticals, Inc.
(STSA)
461,286
-87%
3,250,000
$0.71
$2,294,500.00
BUY
14 Nov 2022
Leonard Braden Michael
10% Owner
Satsuma Pharmaceuticals, Inc.
(STSA)
6,139,306
+2141%
6,440,000
$0.68
$4,394,272.50
BUY
24 Nov 2021
COMMODORE CAPITAL LP
10% Owner
Satsuma Pharmaceuticals, Inc.
(STSA)
3,711,286
+0%
2,922
$5.42
$15,837.24
BUY
19 Nov 2021
COMMODORE CAPITAL LP
10% Owner
Satsuma Pharmaceuticals, Inc.
(STSA)
3,708,364
+0%
13,204
$5.48
$72,328.70
BUY
10 Nov 2021
COMMODORE CAPITAL LP
10% Owner
Satsuma Pharmaceuticals, Inc.
(STSA)
3,695,160
+0%
17,563
$5.94
$104,331.75
BUY
8 Nov 2021
COMMODORE CAPITAL LP
10% Owner
Satsuma Pharmaceuticals, Inc.
(STSA)
3,677,597
+0%
560
$5.99
$3,354.40
BUY
4 Nov 2021
COMMODORE CAPITAL LP
10% Owner
Satsuma Pharmaceuticals, Inc.
(STSA)
3,677,037
+0%
9,200
$5.94
$54,642.00
BUY
2 Nov 2021
COMMODORE CAPITAL LP
10% Owner
Satsuma Pharmaceuticals, Inc.
(STSA)
3,667,837
+0%
8,880
$5.64
$50,083.20
BUY
29 Oct 2021
COMMODORE CAPITAL LP
10% Owner
Satsuma Pharmaceuticals, Inc.
(STSA)
3,658,957
+1%
44,651
$5.71
$254,957.22
BUY
27 Oct 2021
COMMODORE CAPITAL LP
10% Owner
Satsuma Pharmaceuticals, Inc.
(STSA)
3,614,306
+1%
54,663
$5.48
$299,421.53
BUY
21 Oct 2021
COMMODORE CAPITAL LP
10% Owner
Satsuma Pharmaceuticals, Inc.
(STSA)
3,559,643
+1%
60,445
$5.45
$329,442.20
BUY
19 Oct 2021
COMMODORE CAPITAL LP
10% Owner
Satsuma Pharmaceuticals, Inc.
(STSA)
3,499,198
+3%
128,243
$5.19
$665,237.40
BUY
15 Oct 2021
COMMODORE CAPITAL LP
10% Owner
Satsuma Pharmaceuticals, Inc.
(STSA)
3,370,955
+5%
162,194
$4.84
$784,844.75
BUY
26 Feb 2021
RA CAPITAL MANAGEMENT, L.P.
Director, 10% Owner
Satsuma Pharmaceuticals, Inc.
(STSA)
5,155,854
+31%
1,232,394
$5.68
$6,999,997.50
SELL
1 Sep 2020
ALBRECHT DETLEF
Chief Medical Officer, Officer
Satsuma Pharmaceuticals, Inc.
(STSA)
20,212
-4%
1,000
$22.21
$22,210.00
SELL
1 Sep 2020
O'Neil Thomas P.
Chief Financial Officer, Officer
Satsuma Pharmaceuticals, Inc.
(STSA)
0
-100%
750
$22.19
$16,644.53
SELL
5 Aug 2020
O'Neil Thomas P.
Chief Financial Officer, Officer
Satsuma Pharmaceuticals, Inc.
(STSA)
0
-100%
1,000
$25.00
$25,000.00
SELL
3 Aug 2020
ALBRECHT DETLEF
Chief Medical Officer, Officer
Satsuma Pharmaceuticals, Inc.
(STSA)
20,212
-4%
1,000
$22.91
$22,905.62
SELL
1 Jul 2020
O'Neil Thomas P.
Chief Financial Officer, Officer
Satsuma Pharmaceuticals, Inc.
(STSA)
0
-100%
1,000
$26.65
$26,653.92
SELL
1 Jul 2020
ALBRECHT DETLEF
Chief Medical Officer, Officer
Satsuma Pharmaceuticals, Inc.
(STSA)
20,212
-4%
1,000
$26.68
$26,683.05
SELL
23 Jun 2020
O'Neil Thomas P.
Chief Financial Officer, Officer
Satsuma Pharmaceuticals, Inc.
(STSA)
0
-100%
2,115
$35.23
$74,511.88
SELL
1 Jun 2020
ALBRECHT DETLEF
Chief Medical Officer, Officer
Satsuma Pharmaceuticals, Inc.
(STSA)
20,212
-4%
1,000
$25.26
$25,256.90
SELL
1 Jun 2020
O'Neil Thomas P.
Chief Financial Officer, Officer
Satsuma Pharmaceuticals, Inc.
(STSA)
0
-100%
1,000
$25.32
$25,323.50
SELL
20 May 2020
O'Neil Thomas P.
Chief Financial Officer, Officer
Satsuma Pharmaceuticals, Inc.
(STSA)
0
-100%
2,000
$25.00
$50,000.00
SELL
5 May 2020
ALBRECHT DETLEF
Chief Medical Officer, Officer
Satsuma Pharmaceuticals, Inc.
(STSA)
20,212
-4%
1,000
$20.00
$20,000.00
SELL
14 Apr 2020
ALBRECHT DETLEF
Chief Medical Officer, Officer
Satsuma Pharmaceuticals, Inc.
(STSA)
20,012
-3%
800
$20.00
$16,000.00
SELL
1 Apr 2020
ALBRECHT DETLEF
Chief Medical Officer, Officer
Satsuma Pharmaceuticals, Inc.
(STSA)
20,012
-0%
200
$20.25
$4,049.00
SELL
11 Mar 2020
ALBRECHT DETLEF
Chief Medical Officer, Officer
Satsuma Pharmaceuticals, Inc.
(STSA)
20,212
-4%
1,000
$27.42
$27,422.40
SELL
11 Mar 2020
O'Neil Thomas P.
Chief Financial Officer, Officer
Satsuma Pharmaceuticals, Inc.
(STSA)
0
-100%
1,000
$27.68
$27,678.00
BUY
17 Sep 2019
TPG Group Holdings (SBS) Advisors, Inc.
10% Owner
Satsuma Pharmaceuticals, Inc.
(STSA)
1,885,939
+5%
100,000
$15.00
$1,500,000.00
BUY
17 Sep 2019
RA CAPITAL MANAGEMENT, LLC
Director, 10% Owner
Satsuma Pharmaceuticals, Inc.
(STSA)
4,681,858
+39%
1,333,333
$15.00
$19,999,996.00
BUY
17 Sep 2019
Shah Rajeev M.
Director, 10% Owner
Satsuma Pharmaceuticals, Inc.
(STSA)
4,489,471
+42%
1,333,333
$15.00
$19,999,996.00
BUY
17 Sep 2019
TAKANASHI KEN
Director
Satsuma Pharmaceuticals, Inc.
(STSA)
1,561,719
+17%
233,333
$15.00
$3,499,995.00
Home